A £1.5bn (€2.2bn) bidding war for Warner Chilcott loomed today after the Northern Ireland-based pharmaceuticals group revealed a second takeover approach.

Galen Holdings has signed a letter of intent with Barr Laboratories removing the patent risk over three of its four products.

Pharmaceuticals business Galen Holdings has completed the acquisition of femhrt, the hormone replacement therapy.